Clinical Trials Directory

Trials / Completed

CompletedNCT00168441

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
117 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

4-month study including a 30-day baseline phase

Conditions

Interventions

TypeNameDescription
DRUGBotulinum Toxin Type A

Timeline

Start date
2004-06-01
Primary completion
2005-06-01
Completion
2005-06-01
First posted
2005-09-15
Last updated
2011-05-30

Source: ClinicalTrials.gov record NCT00168441. Inclusion in this directory is not an endorsement.

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia (NCT00168441) · Clinical Trials Directory